Filing Details
- Accession Number:
- 0001140361-17-034864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 20:23:28
- Reporting Period:
- 2017-09-05
- Accepted Time:
- 2017-09-07 20:23:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1564926 | R. Patrick O'neil | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Svp, Legal And General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-05 | 200 | $7.25 | 10,633 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-05 | 200 | $55.00 | 10,433 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-09-06 | 800 | $7.25 | 11,233 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-06 | 800 | $55.00 | 10,433 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Commonstock | Employee Stock Option (right to buy) | Disposition | 2017-09-05 | 200 | $0.00 | 200 | $7.25 |
Commonstock | Employee Stock Option (right to buy) | Disposition | 2017-09-06 | 800 | $0.00 | 800 | $7.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,000 | 2016-01-03 | 2019-01-02 | No | 4 | M | Direct |
200 | 2016-01-03 | 2019-01-02 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 6/30/2017.